Box score
Enliven Therapeutics, Inc.
Reported $90M sold in a new Form D filed April 3, 2024 (Boulder, Colorado).
- Biggest raise
- $90M filed Apr 3, 2024
- League
- Bio & Health Pharmaceuticals
- Based in
- Boulder, Colorado
- Season rank
- #55 of 1,389 in the Bio & Health League; #218 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-04-03 | New notice | $90M | $90M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1672619.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | OnKure Therapeutics, Inc. | Bio & Health | $65M |
| 2 | Soar Health Inc. | Bio & Health | $19.3M |
| 3 | CoRegen, Inc. rookie | Bio & Health | $14.5M |
| 4 | OncoVerity, Inc. | Bio & Health | $14M |
| 5 | Ambrosia Biosciences Inc. rookie | Bio & Health | $12.5M |
| 6 | STAQ Pharma, Inc. | Bio & Health | $11.4M |